超音波品质保证模型市场（按模型类型、材质、应用和最终用户划分）—2026-2032年全球预测

2025 年超音波品质保证模型市值为 1.9948 亿美元，预计到 2026 年将成长至 2.1827 亿美元，复合年增长率为 6.38%，到 2032 年将达到 3.0762 亿美元。

关键市场统计数据
基准年 2025	1.9948亿美元
预计年份：2026年	2.1827亿美元
预测年份 2032	3.0762亿美元
复合年增长率 (%)	6.38%

超音波品质保证模型全面介绍：重点关注临床需求、技术驱动因素、监管压力和优先事项

超音波品质保证模型是临床、学术和製造环境中确保诊断准确性、设备可靠性和操作人员能力的重要工具。这些工程模型模拟组织特性，校正影像系统，并检验多普勒测量结果，从而实现可重复的性能检查，确保病患安全和提升诊断信心。随着超音波应用在各个专科领域的日益普及，模型的作用也从简单的校准目标演变为支援先进成像模式和符合监管要求的复杂模拟器。

人工智慧、尖端材料、混合测试方法以及日益严格的监管要求正在推动超音波体检验的变革性转变

超音波模体领域正经历变革时期，其驱动力来自于技术进步、临床工作流程的改变以及新型製造技术的整合。人工智慧和演算法影像处理技术的进步推动了对能够在不同扫描仪型号和软体版本中提供一致、可重复标准的模体的需求。同时，结合实体模体数位双胞胎的混合测试方法和扩展检验通讯协定正变得越来越重要，使开发人员和临床团队能够将类比、台架测试和现场性能评估连接起来，形成闭环。

评估2025年美国关税对超音波品质保证模型供应链、零件采购和製造成本的影响

2025年生效的美国关税对全球供应链产生了累积影响，直接影响超音波保证模型製造所需零件的供应和稳定性。由于许多模型依赖进口原材料、精密零件和专用製造材料，关税上调及相关贸易措施改变了筹资策略，并增加了跨境采购的实际复杂性。为此，製造商正在重新评估其供应商组合，优先考虑关键零件的近岸采购，并寻找既能保持性能又能减少对受关税影响进口产品依赖的替代材料。

对模型类型、材料选择、应用重点和最终用户画像的细分洞察会影响技术优先顺序和购买行为。

对这种细分市场的详细分析揭示了不同的技术和商业性路径如何影响产品设计、采购和最终应用。按模型类型划分，产品包括用于常规系统检查的顺应性模型、专用于流量和速度检验的多普勒模型、用于刚度映射的弹性成像模型、用于受控流体动态测试的流动模型以及可模拟声学和散射特性的组织模拟模型。每种类型的模型对材料均匀性、目标几何形状和使用寿命稳定性都有不同的要求，这些技术要求直接体现在买卖双方的规格讨论中。

对美洲、欧洲、中东和非洲以及亚太地区的需求趋势、供应动态、监管因素和创新情况进行区域性洞察

区域趋势对品质保证模型领域的采购政策、法规要求和创新路径有显着影响。在美洲，市场需求着重于临床吞吐量和符合认证机构的要求，这要求供应商优先提供功能强大、易于使用且能顺利整合到高频诊断环境中的模型。此外，由于接近性大型医院系统和密集的诊断中心网络，物流、快速更换週期和服务水准保证也成为关注的重点。

分析主要企业如何透过工程实力、伙伴关係关係、严格的品质通讯协定和商业化策略来推进超音波保证模型的发展。

超音波模体领域的主要企业凭藉深厚的工程技术、灵活的供应链以及将产品设计与检验的性能数据相结合的能力而脱颖而出。一些製造商专注于材料科学创新，以生产出更耐用、声学保真度更高的模体；而另一些製造商则将模组化和易于整合到临床工作流程中作为其核心竞争优势。与成像设备製造商和研究机构建立策略合作伙伴关係已成为共同开发解决方案的关键途径，这些解决方案能够直接与设备功能和软体更新相匹配，从而实现测试模型与特定成像平台要求的紧密契合。

为产业领导者提供切实可行的建议，以加强品质保证模型开发、提高供应链韧性并加速临床整合

我们鼓励行业领导者采取一系列切实可行的倡议，使其产品系列与不断变化的临床需求和供应实际情况相适应。首先，优先投资于能够延长模型使用寿命并增强高级模型逼真度的材料和设计。这将有助于开展高保真度的培训和评估，同时降低临床客户的整体拥有成本。其次，考虑实现供应商多元化，并发展区域生产伙伴关係，以降低贸易摩擦风险并缩短前置作业时间。结合严格的库存计划，这些措施将提高营运韧性。

透明的调查方法，解释了资料收集、检验通讯协定、相关人员访谈、实验室测试方法和分析框架。

本报告的研究结合了与关键相关人员的对话、实验室验证以及对第二手资料的整合，以确保得出可靠且可操作的结论。主要资料收集工作包括对临床使用者、采购专业人员、学术研究人员和产品开发团队进行结构化检验，以全面了解操作人员培训、效能评估和系统校准等方面的需求。同时，实验室测试通讯协定在标准化条件下，针对代表性模型类型检验了声学保真度、耐久性和可重复性等关键指标，确保技术评估具有可重复性，并与实际应用环境相关。

一份权威的综合报告，重点阐述了品质保证模型在临床实践、研究重点、生产策略和合作方面的意义，以提高其有效性。

技术趋势、供应链发展、市场细分洞察和区域趋势的整合，为临床实践、产品开发和筹资策略提供了明确的启示。临床医生和培训主管应优先选择与特定设备要求和操作流程高度匹配的模型，以最大限度地提高培训效果和诊断一致性。研究人员和学术团队可以利用先进的材料选择和模组化模型结构，设计可重复且适用于不同设备的通用研究。同时，製造商必须在创新与可验证的可重复性和高品质文件之间取得平衡，以满足机构的期望。

目录

第一章：序言

第二章调查方法

• 研究设计
• 研究框架
• 市场规模预测
• 数据三角测量
• 调查结果
• 调查前提
• 调查限制

第三章执行摘要

• 首席主管观点
• 市场规模和成长趋势
• 2025年市占率分析
• FPNV定位矩阵，2025
• 新的商机
• 下一代经营模式
• 产业蓝图

第四章 市场概览

• 产业生态系与价值链分析
• 波特五力分析
• PESTEL 分析
• 市场展望
• 上市策略

第五章 市场洞察

• 消费者洞察与终端用户观点
• 消费者体验基准
• 机会地图
• 分销通路分析
• 价格趋势分析
• 监理合规和标准框架
• ESG与永续性分析
• 中断和风险情景
• 投资报酬率和成本效益分析

第六章：美国关税的累积影响，2025年

第七章：人工智慧的累积影响，2025年

第八章 依模体类型分類的超音波品质保证模体市场

• 遵守
• 多普勒
• 弹性成像
• 流动
• 组织拟态

第九章超音波品质保证模体市场（依材料分类）

• 琼脂
• 凝胶蜡
• 聚氯乙烯塑性溶胶

第十章超音波品质保证模体市场（依应用领域划分）

• 操作员培训
• 绩效评估
• 系统校准

第十一章超音波品质保证模体市场（以最终用户划分）

• 学术和研究机构
• 诊断中心
• 医院和诊所
• 原始设备製造商

第十二章 各地区超音波品质保证模体市场

• 美洲
  • 北美洲
  • 拉丁美洲
• 欧洲、中东和非洲
  • 欧洲
  • 中东
  • 非洲
• 亚太地区

第十三章超音波品质保证模组市场：依组别划分

• ASEAN
• GCC
• EU
• BRICS
• G7
• NATO

第十四章 各国超音波品质保证模体市场

• 美国
• 加拿大
• 墨西哥
• 巴西
• 英国
• 德国
• 法国
• 俄罗斯
• 义大利
• 西班牙
• 中国
• 印度
• 日本
• 澳洲
• 韩国

第十五章：美国超音波品质保证模型市场

第十六章：中国超音波品质保证模体市场

第十七章 竞争格局

• 市场集中度分析，2025年
  • 浓度比（CR）
  • 赫芬达尔-赫希曼指数 (HHI)
• 近期趋势及影响分析，2025 年
• 2025年产品系列分析
• 基准分析，2025 年
• Acertara Acoustic Laboratories, LLC
• Advanced Technical Systems, Inc.
• B&L Engineering
• CIRS, Inc.
• Computerized Imaging Reference Systems, Inc.
• DATASCIENCE International
• GAMMEX, Inc.
• General Research of Electronics, Inc.
• Imaging Phantom Services LLC
• Kyoto Electronics Manufacturing Co., Ltd.
• Odel, Inc.
• Penta Incorporated
• Phantom Laboratory, Inc.
• Sun Nuclear Corporation

The Ultrasound QA Phantoms Market was valued at USD 199.48 million in 2025 and is projected to grow to USD 218.27 million in 2026, with a CAGR of 6.38%, reaching USD 307.62 million by 2032.

KEY MARKET STATISTICS
Base Year [2025]	USD 199.48 million
Estimated Year [2026]	USD 218.27 million
Forecast Year [2032]	USD 307.62 million
CAGR (%)	6.38%

Comprehensive introduction to ultrasound quality assurance phantoms highlighting clinical needs, technological drivers, regulatory pressures, and priorities

Ultrasound quality assurance phantoms serve as foundational tools across clinical, academic, and manufacturing environments, ensuring diagnostic accuracy, device reliability, and operator competency. These engineered test objects mimic tissue properties, calibrate imaging systems, validate Doppler measurements, and enable reproducible performance checks that underpin patient safety and diagnostic confidence. As ultrasound applications proliferate across specialties, the role of phantoms has evolved from simple calibration objects to sophisticated simulators that support advanced modalities and regulatory compliance.

Consequently, stakeholders from hospitals and diagnostic centers to academic and research institutes and original equipment manufacturers rely on phantoms not only to confirm device operation but also to support training, quality management systems, and product development cycles. In parallel, advances in materials science and imaging technologies have raised expectations for realism, repeatability, and long-term stability. Therefore, an informed introduction to this landscape must connect technical capabilities with clinical needs, operational constraints, and procurement realities, enabling leaders to align specifications with intended use cases. By framing the primary functions, current pressures, and emerging priorities, this section establishes the baseline understanding required for more detailed analysis that follows.

Transformative shifts reshaping ultrasound phantom validation driven by AI, advanced materials, hybrid testing methods, and heightened regulatory expectations

The ultrasound phantom landscape is undergoing a period of transformation driven by converging technological advances, shifting clinical workflows, and novel manufacturing techniques. Artificial intelligence and algorithmic image processing have heightened demand for phantoms that provide consistent, reproducible reference standards across diverse scanner models and software versions. Simultaneously, hybrid testing approaches that combine physical phantoms with digital twins and augmented validation protocols are becoming more prominent, enabling developers and clinical teams to close the loop between simulation, bench testing, and in-field performance assessment.

Material innovations, including composites and improved polymer formulations, now deliver longer-lasting, more tissue-realistic targets for elastography and Doppler validation. In addition, modular phantom architectures support interchangeable inserts for multi-parametric validation, which reduces inventory burdens and increases testing flexibility. Regulatory expectations and an emphasis on standardized protocols have also compelled suppliers to document test repeatability and traceability more rigorously. As a result, manufacturers and end users are recalibrating procurement criteria to favor products that combine technical rigor with operational adaptability, while clinical teams prioritize phantoms that align closely with real-world imaging conditions and workflow constraints.

Assessment of 2025 United States tariff effects on supply chains, component sourcing, and manufacturing costs affecting availability and resilience of QA phantoms

Tariff measures enacted by the United States in 2025 have produced cumulative effects across global supply chains that directly influence the availability and resilience of components used in ultrasound QA phantom production. Many phantoms rely on imported raw materials, precision components, and specialized manufacturing inputs; consequently, elevated duties and related trade measures have altered sourcing strategies and increased the practical complexity of cross-border procurement. In response, manufacturers have reassessed supplier portfolios, prioritized nearshoring for critical components, and explored alternate material selections that preserve performance while reducing dependency on tariff-affected imports.

Beyond immediate procurement impacts, these trade actions have influenced lead times and vendor relationships, prompting buyers to place longer planning horizons on orders and to invest in buffer inventories where feasible. Moreover, suppliers have adapted pricing and contractual terms to account for tariff pass-through and to maintain predictable delivery commitments. In parallel, increased attention to domestic certification and compliance requirements has accelerated conversations about localized production capacity. Together, these changes have encouraged a more strategic approach to sourcing decisions, placing resilience and supplier diversity at the center of procurement and product development planning for QA phantoms.

Segmentation insights on phantom type, material selection, application focus, and end user profiles that influence technical priorities and purchasing behavior

A granular view of segmentation reveals how distinct technical and commercial pathways shape product design, procurement, and end use. When distinguishing by phantom type, offerings encompass compliance phantoms for routine system checks, Doppler phantoms tailored to flow and velocity validation, elastography phantoms designed for stiffness mapping, flow phantoms for controlled fluid dynamics testing, and tissue mimicking phantoms that replicate acoustic and scattering properties. Each type imposes different requirements for material homogeneity, target geometry, and lifetime stability, and these technical demands translate directly into specification conversations between purchasers and suppliers.

Material selection further differentiates product lines: commonly used substrates include agar formulations prized for acoustic fidelity, gel wax variants that balance durability and handling, and PVC plastisol solutions that offer extended shelf life and manufacturing consistency. These material choices influence the ease of customization, transportability, and storage protocols. Applications also govern design trade-offs: operator training phantoms emphasize anatomical realism and repeatable pathology simulation, performance evaluation tools prioritize measurement accuracy and statistical repeatability, and system calibration assets focus on standardized targets and traceable markers. End user classification shapes purchasing priorities and service expectations; academic and research institutes may prioritize versatility and documentation for reproducible studies, diagnostic centers often emphasize throughput and cost efficiency, hospitals and clinics require durable, low-maintenance solutions aligned with clinical workflows, and original equipment manufacturers look for integration-ready phantoms that support product validation and warranty processes. Collectively, these segmentation lenses clarify where value accrues and where product refinement yields the greatest operational impact.

Regional insights into demand, supply dynamics, regulatory drivers, and innovation across Americas, Europe Middle East & Africa, and Asia-Pacific

Regional dynamics exert a strong influence on procurement preferences, regulatory expectations, and innovation pathways in the QA phantom domain. In the Americas, demand emphasizes clinical throughput and compliance with established accrediting bodies; this environment encourages suppliers to prioritize robust, easy-to-use phantoms that integrate smoothly into high-volume diagnostic settings. In addition, proximity to large hospital systems and a dense network of diagnostic centers drives a focus on logistics, rapid replacement cycles, and service-level commitments.

Conversely, Europe, Middle East & Africa presents a mosaic of regulatory regimes and clinical practices that reward adaptable product families and strong technical documentation. Suppliers operating in this region must navigate varying standards while offering modular solutions that can be customized for differing clinical norms and training programs. Meanwhile, Asia-Pacific demonstrates accelerated adoption of advanced imaging modalities and rapid expansion of academic and clinical infrastructure, which stimulates demand for phantoms that support advanced modalities such as elastography and high-frequency imaging. Across all regions, however, regulatory harmonization efforts and increasing emphasis on reproducibility incentivize suppliers to deliver transparent product validation data and to develop regional support networks that reduce lead times and improve in-country service responsiveness.

Analysis of leading companies advancing ultrasound QA phantoms via engineering strengths, partnerships, rigorous quality protocols, and commercialization strategies

Leading companies in the ultrasound phantom space are differentiating through engineering depth, supply chain agility, and the ability to couple product design with validated performance data. Some manufacturers emphasize materials science innovations to produce phantoms with improved longevity and acoustic fidelity, while others center their competitive positioning on modularity and ease of integration into clinical workflows. Strategic partnerships with imaging OEMs and research institutions have become a vital route to co-develop solutions that map directly to device capabilities and software updates, enabling closer alignment between test artifacts and the requirements of specific imaging platforms.

Furthermore, firms that invest in rigorous quality assurance protocols and transparent validation reporting create stronger credibility among clinical customers and regulatory stakeholders. Companies that maintain diversified manufacturing footprints and robust distribution networks also demonstrate superior responsiveness to procurement cycles and supply disruptions. As purchasers increasingly seek documented repeatability and traceability, vendors that can provide detailed test reports, long-term stability data, and calibration support stand to capture preference among sophisticated buyers. Collectively, these strategic directions indicate that competitive advantage arises from a blend of technical excellence, partnership ecosystems, and operational reliability.

Practical recommendations for industry leaders to strengthen development, improve supply resilience, and accelerate clinical integration of QA phantoms

Industry leaders should pursue a suite of pragmatic actions to align product portfolios with evolving clinical needs and supply realities. First, prioritize investments in materials and design that extend phantom longevity and enhance realism for advanced modalities; this will reduce total cost of ownership for clinical customers while supporting high-fidelity training and evaluation. Second, diversify supplier bases and consider regional production partnerships to mitigate exposure to trade actions and to shorten lead times; in combination with denser inventory planning, these steps will improve operational resilience.

Third, strengthen collaboration with imaging system manufacturers and academic partners to co-develop validation protocols that reflect contemporary software and hardware configurations, thereby enhancing the relevance of phantoms for both product development and clinical training. Fourth, expand documentation and certification offerings to meet the expectations of regulators and institutional purchasers; detailed validation data and traceable calibration procedures will accelerate adoption and simplify procurement. Finally, adopt flexible commercialization models, including modular bundles and service agreements that allow buyers to scale capability incrementally. By implementing these recommendations, suppliers and institutional buyers can better navigate technical complexity, regulatory demands, and supply chain constraints while delivering consistent, clinically relevant outcomes.

Transparent research methodology describing data collection, validation protocols, stakeholder interviews, laboratory testing approaches, and analytical frameworks

The research underpinning this report combines primary stakeholder engagement, laboratory verification, and secondary source synthesis to ensure robust, actionable findings. Primary data collection included structured interviews with clinical users, procurement specialists, academic investigators, and product development teams, enabling a nuanced view of requirements across operator training, performance evaluation, and system calibration contexts. In parallel, laboratory testing protocols verified key claims around acoustic fidelity, durability, and repeatability for representative phantom types under standardized conditions, ensuring that technical evaluations are reproducible and relevant to real-world use.

Secondary research supported contextual analysis of materials trends and supply chain patterns, drawing on regulatory guidance and industry best practices to frame compliance and documentation expectations. Validation steps included cross-referencing interview insights with laboratory outcomes and supplier documentation to reconcile observed performance with stated specifications. Analytical frameworks emphasized segmentation across phantom type, material, application, and end user to reveal actionable differentials. Together, these methods provide a transparent foundation for the conclusions and recommendations presented, and they enable stakeholders to trace findings back to source inputs and validation steps.

Conclusive synthesis highlighting implications for clinical practice, research priorities, manufacturing strategy, and collaboration to advance QA phantom effectiveness

The synthesis of technical trends, supply chain developments, segmentation insights, and regional dynamics yields clear implications for clinical practice, product development, and procurement strategy. Clinicians and training directors should prioritize phantoms that align closely with modality-specific requirements and operational workflows to maximize training efficacy and diagnostic consistency. Researchers and academic groups can leverage advanced material options and modular phantom architectures to design reproducible studies that generalize across devices, while manufacturers should balance innovation with demonstrable repeatability and quality documentation to meet institutional expectations.

From a strategic perspective, supply chain resilience and supplier diversification have emerged as central priorities in light of trade policy changes and component concentration. At the same time, collaboration between vendors, OEMs, and clinical stakeholders will accelerate development of validation protocols that map directly to device functionality. In sum, a coordinated approach that integrates technical rigor, operational adaptability, and transparent documentation will best position organizations to derive reliable value from ultrasound QA phantoms and to support improved diagnostic outcomes.

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Definition
• 1.3. Market Segmentation & Coverage
• 1.4. Years Considered for the Study
• 1.5. Currency Considered for the Study
• 1.6. Language Considered for the Study
• 1.7. Key Stakeholders

2. Research Methodology

• 2.1. Introduction
• 2.2. Research Design
  • 2.2.1. Primary Research
  • 2.2.2. Secondary Research
• 2.3. Research Framework
  • 2.3.1. Qualitative Analysis
  • 2.3.2. Quantitative Analysis
• 2.4. Market Size Estimation
  • 2.4.1. Top-Down Approach
  • 2.4.2. Bottom-Up Approach
• 2.5. Data Triangulation
• 2.6. Research Outcomes
• 2.7. Research Assumptions
• 2.8. Research Limitations

3. Executive Summary

• 3.1. Introduction
• 3.2. CXO Perspective
• 3.3. Market Size & Growth Trends
• 3.4. Market Share Analysis, 2025
• 3.5. FPNV Positioning Matrix, 2025
• 3.6. New Revenue Opportunities
• 3.7. Next-Generation Business Models
• 3.8. Industry Roadmap

4. Market Overview

• 4.1. Introduction
• 4.2. Industry Ecosystem & Value Chain Analysis
  • 4.2.1. Supply-Side Analysis
  • 4.2.2. Demand-Side Analysis
  • 4.2.3. Stakeholder Analysis
• 4.3. Porter's Five Forces Analysis
• 4.4. PESTLE Analysis
• 4.5. Market Outlook
  • 4.5.1. Near-Term Market Outlook (0-2 Years)
  • 4.5.2. Medium-Term Market Outlook (3-5 Years)
  • 4.5.3. Long-Term Market Outlook (5-10 Years)
• 4.6. Go-to-Market Strategy

5. Market Insights

• 5.1. Consumer Insights & End-User Perspective
• 5.2. Consumer Experience Benchmarking
• 5.3. Opportunity Mapping
• 5.4. Distribution Channel Analysis
• 5.5. Pricing Trend Analysis
• 5.6. Regulatory Compliance & Standards Framework
• 5.7. ESG & Sustainability Analysis
• 5.8. Disruption & Risk Scenarios
• 5.9. Return on Investment & Cost-Benefit Analysis

6. Cumulative Impact of United States Tariffs 2025

7. Cumulative Impact of Artificial Intelligence 2025

8. Ultrasound QA Phantoms Market, by Phantom Type

• 8.1. Compliance
• 8.2. Doppler
• 8.3. Elastography
• 8.4. Flow
• 8.5. Tissue Mimicking

9. Ultrasound QA Phantoms Market, by Material

• 9.1. Agar
• 9.2. Gel Wax
• 9.3. PVC Plastisol

10. Ultrasound QA Phantoms Market, by Application

• 10.1. Operator Training
• 10.2. Performance Evaluation
• 10.3. System Calibration

11. Ultrasound QA Phantoms Market, by End User

• 11.1. Academic & Research Institutes
• 11.2. Diagnostic Centers
• 11.3. Hospitals & Clinics
• 11.4. Original Equipment Manufacturers

12. Ultrasound QA Phantoms Market, by Region

• 12.1. Americas
  • 12.1.1. North America
  • 12.1.2. Latin America
• 12.2. Europe, Middle East & Africa
  • 12.2.1. Europe
  • 12.2.2. Middle East
  • 12.2.3. Africa
• 12.3. Asia-Pacific

13. Ultrasound QA Phantoms Market, by Group

• 13.1. ASEAN
• 13.2. GCC
• 13.3. European Union
• 13.4. BRICS
• 13.5. G7
• 13.6. NATO

14. Ultrasound QA Phantoms Market, by Country

• 14.1. United States
• 14.2. Canada
• 14.3. Mexico
• 14.4. Brazil
• 14.5. United Kingdom
• 14.6. Germany
• 14.7. France
• 14.8. Russia
• 14.9. Italy
• 14.10. Spain
• 14.11. China
• 14.12. India
• 14.13. Japan
• 14.14. Australia
• 14.15. South Korea

15. United States Ultrasound QA Phantoms Market

16. China Ultrasound QA Phantoms Market

17. Competitive Landscape

• 17.1. Market Concentration Analysis, 2025
  • 17.1.1. Concentration Ratio (CR)
  • 17.1.2. Herfindahl Hirschman Index (HHI)
• 17.2. Recent Developments & Impact Analysis, 2025
• 17.3. Product Portfolio Analysis, 2025
• 17.4. Benchmarking Analysis, 2025
• 17.5. Acertara Acoustic Laboratories, LLC
• 17.6. Advanced Technical Systems, Inc.
• 17.7. B&L Engineering
• 17.8. CIRS, Inc.
• 17.9. Computerized Imaging Reference Systems, Inc.
• 17.10. DATASCIENCE International
• 17.11. GAMMEX, Inc.
• 17.12. General Research of Electronics, Inc.
• 17.13. Imaging Phantom Services LLC
• 17.14. Kyoto Electronics Manufacturing Co., Ltd.
• 17.15. Odel, Inc.
• 17.16. Penta Incorporated
• 17.17. Phantom Laboratory, Inc.
• 17.18. Sun Nuclear Corporation

LIST OF FIGURES

• FIGURE 1. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 2. GLOBAL ULTRASOUND QA PHANTOMS MARKET SHARE, BY KEY PLAYER, 2025
• FIGURE 3. GLOBAL ULTRASOUND QA PHANTOMS MARKET, FPNV POSITIONING MATRIX, 2025
• FIGURE 4. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 5. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 6. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 7. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 8. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY REGION, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 9. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY GROUP, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 10. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2025 VS 2026 VS 2032 (USD MILLION)
• FIGURE 11. UNITED STATES ULTRASOUND QA PHANTOMS MARKET SIZE, 2018-2032 (USD MILLION)
• FIGURE 12. CHINA ULTRASOUND QA PHANTOMS MARKET SIZE, 2018-2032 (USD MILLION)

LIST OF TABLES

• TABLE 1. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 2. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
• TABLE 3. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY COMPLIANCE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 4. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY COMPLIANCE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 5. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY COMPLIANCE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 6. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY DOPPLER, BY REGION, 2018-2032 (USD MILLION)
• TABLE 7. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY DOPPLER, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 8. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY DOPPLER, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 9. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY ELASTOGRAPHY, BY REGION, 2018-2032 (USD MILLION)
• TABLE 10. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY ELASTOGRAPHY, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 11. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY ELASTOGRAPHY, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 12. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY FLOW, BY REGION, 2018-2032 (USD MILLION)
• TABLE 13. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY FLOW, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 14. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY FLOW, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 15. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY TISSUE MIMICKING, BY REGION, 2018-2032 (USD MILLION)
• TABLE 16. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY TISSUE MIMICKING, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 17. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY TISSUE MIMICKING, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 18. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 19. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY AGAR, BY REGION, 2018-2032 (USD MILLION)
• TABLE 20. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY AGAR, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 21. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY AGAR, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 22. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY GEL WAX, BY REGION, 2018-2032 (USD MILLION)
• TABLE 23. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY GEL WAX, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 24. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY GEL WAX, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 25. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY PVC PLASTISOL, BY REGION, 2018-2032 (USD MILLION)
• TABLE 26. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY PVC PLASTISOL, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 27. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY PVC PLASTISOL, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 28. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 29. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY OPERATOR TRAINING, BY REGION, 2018-2032 (USD MILLION)
• TABLE 30. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY OPERATOR TRAINING, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 31. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY OPERATOR TRAINING, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 32. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY PERFORMANCE EVALUATION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 33. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY PERFORMANCE EVALUATION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 34. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY PERFORMANCE EVALUATION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 35. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY SYSTEM CALIBRATION, BY REGION, 2018-2032 (USD MILLION)
• TABLE 36. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY SYSTEM CALIBRATION, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 37. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY SYSTEM CALIBRATION, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 38. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 39. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY REGION, 2018-2032 (USD MILLION)
• TABLE 40. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 41. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY ACADEMIC & RESEARCH INSTITUTES, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 42. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 43. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 44. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY DIAGNOSTIC CENTERS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 45. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY HOSPITALS & CLINICS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 46. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY HOSPITALS & CLINICS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 47. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY HOSPITALS & CLINICS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 48. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY ORIGINAL EQUIPMENT MANUFACTURERS, BY REGION, 2018-2032 (USD MILLION)
• TABLE 49. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY ORIGINAL EQUIPMENT MANUFACTURERS, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 50. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY ORIGINAL EQUIPMENT MANUFACTURERS, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 51. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY REGION, 2018-2032 (USD MILLION)
• TABLE 52. AMERICAS ULTRASOUND QA PHANTOMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 53. AMERICAS ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
• TABLE 54. AMERICAS ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 55. AMERICAS ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 56. AMERICAS ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 57. NORTH AMERICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 58. NORTH AMERICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
• TABLE 59. NORTH AMERICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 60. NORTH AMERICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 61. NORTH AMERICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 62. LATIN AMERICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 63. LATIN AMERICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
• TABLE 64. LATIN AMERICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 65. LATIN AMERICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 66. LATIN AMERICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 67. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY SUBREGION, 2018-2032 (USD MILLION)
• TABLE 68. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
• TABLE 69. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 70. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 71. EUROPE, MIDDLE EAST & AFRICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 72. EUROPE ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 73. EUROPE ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
• TABLE 74. EUROPE ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 75. EUROPE ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 76. EUROPE ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 77. MIDDLE EAST ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 78. MIDDLE EAST ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
• TABLE 79. MIDDLE EAST ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 80. MIDDLE EAST ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 81. MIDDLE EAST ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 82. AFRICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 83. AFRICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
• TABLE 84. AFRICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 85. AFRICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 86. AFRICA ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 87. ASIA-PACIFIC ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 88. ASIA-PACIFIC ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
• TABLE 89. ASIA-PACIFIC ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 90. ASIA-PACIFIC ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 91. ASIA-PACIFIC ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 92. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY GROUP, 2018-2032 (USD MILLION)
• TABLE 93. ASEAN ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 94. ASEAN ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
• TABLE 95. ASEAN ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 96. ASEAN ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 97. ASEAN ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 98. GCC ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 99. GCC ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
• TABLE 100. GCC ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 101. GCC ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 102. GCC ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 103. EUROPEAN UNION ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 104. EUROPEAN UNION ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
• TABLE 105. EUROPEAN UNION ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 106. EUROPEAN UNION ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 107. EUROPEAN UNION ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 108. BRICS ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 109. BRICS ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
• TABLE 110. BRICS ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 111. BRICS ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 112. BRICS ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 113. G7 ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 114. G7 ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
• TABLE 115. G7 ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 116. G7 ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 117. G7 ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 118. NATO ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 119. NATO ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
• TABLE 120. NATO ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 121. NATO ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 122. NATO ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 123. GLOBAL ULTRASOUND QA PHANTOMS MARKET SIZE, BY COUNTRY, 2018-2032 (USD MILLION)
• TABLE 124. UNITED STATES ULTRASOUND QA PHANTOMS MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 125. UNITED STATES ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
• TABLE 126. UNITED STATES ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 127. UNITED STATES ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 128. UNITED STATES ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)
• TABLE 129. CHINA ULTRASOUND QA PHANTOMS MARKET SIZE, 2018-2032 (USD MILLION)
• TABLE 130. CHINA ULTRASOUND QA PHANTOMS MARKET SIZE, BY PHANTOM TYPE, 2018-2032 (USD MILLION)
• TABLE 131. CHINA ULTRASOUND QA PHANTOMS MARKET SIZE, BY MATERIAL, 2018-2032 (USD MILLION)
• TABLE 132. CHINA ULTRASOUND QA PHANTOMS MARKET SIZE, BY APPLICATION, 2018-2032 (USD MILLION)
• TABLE 133. CHINA ULTRASOUND QA PHANTOMS MARKET SIZE, BY END USER, 2018-2032 (USD MILLION)